|
|
blastocyst growth
|
GO:0001832 |
23 |
1.000
|
|
|
|
inner cell mass cell proliferation
|
GO:0001833 |
15 |
1.000
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
1.000
|
|
|
|
protein deacetylation
|
GO:0006476 |
32 |
1.000
|
|
|
|
mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis
|
GO:0072309 |
3 |
0.999
|
|
|
|
mrna transcription from rna polymerase ii promoter
|
GO:0042789 |
4 |
0.998
|
|
|
|
olfactory nerve development
|
GO:0021553 |
3 |
0.998
|
|
|
|
regulation of chromatin silencing
|
GO:0031935 |
2 |
0.996
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.995
|
|
|
|
ureteric bud invasion
|
GO:0072092 |
3 |
0.995
|
|
|
|
negative regulation of posttranscriptional gene silencing
|
GO:0060149 |
1 |
0.993
|
|
|
|
thick ascending limb development
|
GO:0072023 |
2 |
0.992
|
|
|
|
metanephric ascending thin limb development
|
GO:0072218 |
2 |
0.992
|
|
|
|
neurohypophysis development
|
GO:0021985 |
2 |
0.989
|
|
|
|
histone deacetylation
|
GO:0016575 |
26 |
0.988
|
|
|
|
inner cell mass cell fate commitment
|
GO:0001827 |
2 |
0.981
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.979
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.975
|
|
|
|
metanephric thick ascending limb development
|
GO:0072233 |
2 |
0.973
|
|
|
|
ectodermal cell differentiation
|
GO:0010668 |
3 |
0.970
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.959
|
|
|
|
inner cell mass cell differentiation
|
GO:0001826 |
7 |
0.957
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.957
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.956
|
|
|
|
chromatin silencing
|
GO:0006342 |
15 |
0.941
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.935
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.934
|
|
|
|
metanephric renal vesicle formation
|
GO:0072093 |
4 |
0.932
|
|
|
|
epithalamus development
|
GO:0021538 |
2 |
0.929
|
|
|
|
habenula development
|
GO:0021986 |
2 |
0.920
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.907
|
|
|
|
regulation of heart induction by regulation of canonical wnt signaling pathway
|
GO:0090081 |
2 |
0.902
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.894
|
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.893
|
|
|
|
proprioception
|
GO:0019230 |
4 |
0.893
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.887
|
|
|
|
somatotropin secreting cell development
|
GO:0060133 |
2 |
0.886
|
|
|
|
negative regulation of calcium ion dependent exocytosis
|
GO:0045955 |
3 |
0.883
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.872
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.868
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.860
|
|
|
|
olfactory bulb interneuron development
|
GO:0021891 |
7 |
0.860
|
|
|
|
protein deacylation
|
GO:0035601 |
36 |
0.859
|
|
|
|
ureteric bud elongation
|
GO:0060677 |
6 |
0.858
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.850
|
|
|
|
metanephric macula densa development
|
GO:0072227 |
1 |
0.834
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.831
|
|
|
|
metanephric dct cell differentiation
|
GO:0072240 |
3 |
0.826
|
|
|
|
eyelid development in camera type eye
|
GO:0061029 |
9 |
0.822
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.819
|
|
|
|
ventricular compact myocardium morphogenesis
|
GO:0003223 |
2 |
0.816
|
|
|
|
macula densa development
|
GO:0072024 |
1 |
0.810
|
|
|
|
ascending thin limb development
|
GO:0072021 |
2 |
0.782
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
21 |
0.774
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.735
|
|
|
|
negative regulation of mesoderm development
|
GO:2000381 |
8 |
0.730
|
|
|
|
negative regulation of gene silencing by rna
|
GO:0060967 |
1 |
0.712
|
|
|
|
proprioception involved in equilibrioception
|
GO:0051355 |
1 |
0.705
|
|
|
|
mrna transcription
|
GO:0009299 |
4 |
0.695
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.687
|
|
|
|
dna methylation
|
GO:0006306 |
43 |
0.670
|
|
|
|
regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis
|
GO:0003339 |
5 |
0.637
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.637
|
Human |
|
|
methylation dependent chromatin silencing
|
GO:0006346 |
6 |
0.636
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.626
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.612
|
|
|
|
midbrain hindbrain boundary morphogenesis
|
GO:0021555 |
4 |
0.607
|
|
|
|
positive regulation of catenin import into nucleus
|
GO:0035413 |
2 |
0.602
|
|
|
|
regulation of hippo signaling
|
GO:0035330 |
1 |
0.597
|
|
|
|
dna alkylation
|
GO:0006305 |
43 |
0.588
|
|
|
|
ectodermal cell fate commitment
|
GO:0001712 |
1 |
0.584
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.573
|
|
|
|
renal vesicle development
|
GO:0072087 |
17 |
0.570
|
|
|
|
cranial nerve development
|
GO:0021545 |
41 |
0.565
|
|
|
|
metanephric distal convoluted tubule development
|
GO:0072221 |
5 |
0.557
|
|
|
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.552
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.549
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.549
|
|
|
|
cell cell signaling involved in cell fate commitment
|
GO:0045168 |
35 |
0.547
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.542
|
|
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.540
|
|
|
|
developmental induction
|
GO:0031128 |
34 |
0.539
|
|
|
|
regulation of catenin import into nucleus
|
GO:0035412 |
5 |
0.538
|
|
|
|
loop of henle development
|
GO:0072070 |
10 |
0.530
|
|
|
|
negative regulation of metanephros development
|
GO:0072217 |
6 |
0.529
|
|
|
|
c21 steroid hormone biosynthetic process
|
GO:0006700 |
3 |
0.528
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.514
|
|
|
|
olfactory bulb interneuron differentiation
|
GO:0021889 |
12 |
0.513
|
|
|
|
determination of left right asymmetry in nervous system
|
GO:0035545 |
1 |
0.501
|
|
|
|
face development
|
GO:0060324 |
38 |
0.499
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.495
|
|
|
|
visceral motor neuron differentiation
|
GO:0021524 |
3 |
0.491
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.486
|
|
|
|
cardiac muscle cell myoblast differentiation
|
GO:0060379 |
8 |
0.484
|
|
|
|
adenohypophysis development
|
GO:0021984 |
14 |
0.480
|
|
|
|
organism emergence from protective structure
|
GO:0071684 |
4 |
0.476
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.462
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.458
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.455
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.447
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.447
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.429
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.420
|
|
|
|
dct cell differentiation
|
GO:0072069 |
3 |
0.419
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in heart development
|
GO:1901213 |
9 |
0.418
|
|
|
|
astrocyte development
|
GO:0014002 |
12 |
0.415
|
|
|
|
rostrocaudal neural tube patterning
|
GO:0021903 |
12 |
0.414
|
|
|
|
metanephric juxtaglomerular apparatus development
|
GO:0072206 |
1 |
0.406
|
|
|
|
negative regulation of gene silencing
|
GO:0060969 |
2 |
0.403
|
|
|
|
forelimb morphogenesis
|
GO:0035136 |
40 |
0.401
|
|
|
|
myelination in peripheral nervous system
|
GO:0022011 |
19 |
0.395
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.386
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.384
|
|
|
|
establishment of planar polarity involved in neural tube closure
|
GO:0090177 |
15 |
0.381
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.377
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.375
|
|
|
|
positive regulation of branching involved in ureteric bud morphogenesis
|
GO:0090190 |
18 |
0.365
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.362
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.360
|
|
|
|
mesenchymal to epithelial transition involved in metanephros morphogenesis
|
GO:0003337 |
9 |
0.359
|
|
|
|
olfactory bulb development
|
GO:0021772 |
30 |
0.358
|
|
|
|
regulation of wnt signaling pathway involved in heart development
|
GO:0003307 |
5 |
0.350
|
|
|
|
olfactory lobe development
|
GO:0021988 |
32 |
0.350
|
|
|
|
specification of organ position
|
GO:0010159 |
3 |
0.350
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.347
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003257 |
3 |
0.343
|
|
|
|
negative regulation of androgen receptor signaling pathway
|
GO:0060766 |
3 |
0.337
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.336
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.335
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.334
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.330
|
|
|
|
regulation of inositol phosphate biosynthetic process
|
GO:0010919 |
3 |
0.329
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.322
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.319
|
|
|
|
trophectodermal cellular morphogenesis
|
GO:0001831 |
3 |
0.317
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.312
|
|
|
|
regulation of methylation dependent chromatin silencing
|
GO:0090308 |
1 |
0.310
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.307
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.307
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.305
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.300
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.299
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.289
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.287
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.287
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.283
|
|
|
|
cochlea development
|
GO:0090102 |
35 |
0.282
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.282
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.281
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.278
|
|
|
|
regulation of ectoderm development
|
GO:2000383 |
2 |
0.277
|
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.275
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.275
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.271
|
|
|
|
negative regulation of gene expression epigenetic
|
GO:0045814 |
15 |
0.269
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.265
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.257
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.256
|
|
|
|
cardiac cell fate determination
|
GO:0060913 |
2 |
0.255
|
|
|
|
hypothalamus cell differentiation
|
GO:0021979 |
8 |
0.252
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.246
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.244
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.242
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.241
|
|
|
|
schwann cell development
|
GO:0014044 |
22 |
0.240
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.240
|
|
|
|
hippo signaling
|
GO:0035329 |
11 |
0.239
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.235
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.231
|
|
|
|
mesenchymal to epithelial transition
|
GO:0060231 |
12 |
0.230
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.227
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in heart development
|
GO:1901228 |
4 |
0.225
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
29 |
0.224
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.223
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.220
|
|
|
|
cochlea morphogenesis
|
GO:0090103 |
22 |
0.215
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.210
|
|
|
|
distal convoluted tubule development
|
GO:0072025 |
5 |
0.206
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.204
|
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.198
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.196
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.196
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.191
|
|
|
|
histone h2a ubiquitination
|
GO:0033522 |
3 |
0.190
|
|
|
|
epithelial cell maturation involved in prostate gland development
|
GO:0060743 |
4 |
0.190
|
|
|
|
habituation
|
GO:0046959 |
3 |
0.190
|
|
|
|
positive regulation of extracellular matrix organization
|
GO:1903055 |
4 |
0.189
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.189
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.187
|
|
|
|
negative regulation of kidney development
|
GO:0090185 |
15 |
0.186
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.186
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.186
|
|
|
|
negative regulation of exocytosis
|
GO:0045920 |
12 |
0.180
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.179
|
|
|
|
negative regulation of smoothened signaling pathway
|
GO:0045879 |
25 |
0.175
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.174
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.173
|
|
|
|
regulation of tongue muscle cell differentiation
|
GO:2001035 |
2 |
0.172
|
|
|
|
positive regulation of g0 to g1 transition
|
GO:0070318 |
2 |
0.171
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.170
|
|
|
|
positive regulation of fibroblast growth factor receptor signaling pathway
|
GO:0045743 |
3 |
0.169
|
|
|
|
neuromuscular process controlling posture
|
GO:0050884 |
14 |
0.168
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.168
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.168
|
|
|
|
regulation of mesoderm development
|
GO:2000380 |
12 |
0.167
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.166
|
|
|
|
negative regulation of cardiac chamber formation
|
GO:1901211 |
1 |
0.165
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.165
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.163
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
43 |
0.160
|
|
|
|
aldosterone metabolic process
|
GO:0032341 |
2 |
0.160
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.159
|
|
|
|
metanephros morphogenesis
|
GO:0003338 |
24 |
0.157
|
|
|
|
immunoglobulin secretion involved in immune response
|
GO:0002380 |
2 |
0.156
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.156
|
|
|
|
organ induction
|
GO:0001759 |
21 |
0.155
|
|
|
|
negative regulation of cardiac chamber morphogenesis
|
GO:1901220 |
2 |
0.155
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.155
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.155
|
|
|
|
developmental pigmentation
|
GO:0048066 |
40 |
0.154
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.152
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.152
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.149
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.147
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.147
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.146
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.146
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.145
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.144
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.143
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.143
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.143
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.143
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.142
|
|
|
|
establishment of planar polarity of embryonic epithelium
|
GO:0042249 |
16 |
0.141
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.141
|
|
|
|
ectoderm development
|
GO:0007398 |
15 |
0.140
|
|
|
|
adrenal gland development
|
GO:0030325 |
18 |
0.140
|
|
|
|
regulation of cardiac chamber morphogenesis
|
GO:1901219 |
2 |
0.138
|
|
|
|
midbrain hindbrain boundary development
|
GO:0030917 |
9 |
0.138
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.138
|
|
|
|
ectodermal placode formation
|
GO:0060788 |
16 |
0.138
|
|
|
|
negative regulation of viral process
|
GO:0048525 |
23 |
0.135
|
|
|
|
metanephric renal vesicle morphogenesis
|
GO:0072283 |
12 |
0.134
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.134
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.133
|
Human |
|
|
respiratory system development
|
GO:0060541 |
190 |
0.133
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.132
|
|
|
|
renal vesicle morphogenesis
|
GO:0072077 |
15 |
0.132
|
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.132
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.129
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.129
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.127
|
|
|
|
regulation of transcription from rna polymerase i promoter
|
GO:0006356 |
6 |
0.126
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.126
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.126
|
|
|
|
regulation of heart induction
|
GO:0090381 |
2 |
0.125
|
|
|
|
negative regulation of wnt signaling pathway involved in heart development
|
GO:0003308 |
4 |
0.125
|
|
|
|
regulation of posttranscriptional gene silencing
|
GO:0060147 |
5 |
0.124
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.124
|
|
|
|
epithelial cell maturation
|
GO:0002070 |
15 |
0.124
|
|
|
|
mesodermal to mesenchymal transition involved in gastrulation
|
GO:0060809 |
1 |
0.123
|
|
|
|
dna modification
|
GO:0006304 |
50 |
0.122
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.121
|
|
|
|
fat pad development
|
GO:0060613 |
6 |
0.120
|
|
|
|
tongue muscle cell differentiation
|
GO:0035981 |
2 |
0.120
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.119
|
|
|
|
equilibrioception
|
GO:0050957 |
3 |
0.119
|
|
|
|
endodermal cell fate commitment
|
GO:0001711 |
12 |
0.117
|
Human |
|
|
synapsis
|
GO:0007129 |
34 |
0.117
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.116
|
|
|
|
negative regulation of viral transcription
|
GO:0032897 |
3 |
0.113
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.112
|
|
|
|
negative regulation of ectoderm development
|
GO:2000384 |
2 |
0.112
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.112
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.111
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.111
|
|
|
|
regulation of establishment of planar polarity involved in neural tube closure
|
GO:0090178 |
15 |
0.110
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.109
|
|
|
|
renal vesicle formation
|
GO:0072033 |
8 |
0.108
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.108
|
|
|
|
nose development
|
GO:0043584 |
12 |
0.107
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.106
|
|
|
|
isotype switching
|
GO:0045190 |
36 |
0.106
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.106
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.106
|
|
|
|
regulation of mesonephros development
|
GO:0061217 |
24 |
0.106
|
|
|
|
dna dealkylation
|
GO:0035510 |
11 |
0.105
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.105
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.104
|
|
|
|
dna packaging
|
GO:0006323 |
30 |
0.103
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.103
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.102
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.101
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.101
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.101
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.101
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.100
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.100
|
|
|
|
positive regulation of immature t cell proliferation
|
GO:0033091 |
4 |
0.098
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.098
|
|
|
|
hypothalamus development
|
GO:0021854 |
16 |
0.097
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.097
|
|
|
|
olfactory placode development
|
GO:0071698 |
4 |
0.097
|
|
|
|
regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014717 |
3 |
0.096
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.095
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.095
|
Human |
|
|
smooth muscle tissue development
|
GO:0048745 |
22 |
0.095
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.094
|
|
|
|
regulation of dna methylation
|
GO:0044030 |
12 |
0.094
|
|
|
|
regulation of cardiac chamber formation
|
GO:1901210 |
1 |
0.092
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.091
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.091
|
|
|
|
lens epithelial cell proliferation
|
GO:0097166 |
1 |
0.090
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.090
|
|
|
|
histone h4 acetylation
|
GO:0043967 |
10 |
0.090
|
|
|
|
chromosome organization involved in meiosis
|
GO:0070192 |
39 |
0.089
|
|
|
|
positive regulation of hippo signaling
|
GO:0035332 |
1 |
0.088
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.088
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
36 |
0.088
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.087
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.087
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.086
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.083
|
|
|
|
regulation of transcription involved in primary germ layer cell fate commitment
|
GO:0060796 |
2 |
0.082
|
|
|
|
mesodermal cell differentiation
|
GO:0048333 |
22 |
0.082
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.082
|
|
|
|
regulation of smad protein complex assembly
|
GO:0010990 |
1 |
0.081
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.081
|
|
|
|
chromatin mediated maintenance of transcription
|
GO:0048096 |
2 |
0.079
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.078
|
|
|
|
mineralocorticoid metabolic process
|
GO:0008212 |
2 |
0.078
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.078
|
|
|
|
tongue development
|
GO:0043586 |
18 |
0.078
|
|
|
|
cell differentiation involved in kidney development
|
GO:0061005 |
33 |
0.078
|
|
|
|
positive regulation of inositol trisphosphate biosynthetic process
|
GO:0032962 |
2 |
0.078
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.078
|
|
|
|
regulation of cell cycle g2 m phase transition
|
GO:1902749 |
10 |
0.078
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.077
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.076
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.076
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.076
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.076
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.076
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.076
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.075
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.075
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.074
|
|
|
|
positive regulation of kidney development
|
GO:0090184 |
28 |
0.074
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.074
|
|
|
|
somatic diversification of immune receptors via germline recombination within a single locus
|
GO:0002562 |
51 |
0.074
|
|
|
|
somatic recombination of immunoglobulin gene segments
|
GO:0016447 |
42 |
0.074
|
|
|
|
trophectodermal cell proliferation
|
GO:0001834 |
2 |
0.074
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.072
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.072
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.072
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.072
|
|
|
|
inner cell mass cellular morphogenesis
|
GO:0001828 |
1 |
0.071
|
|
|
|
cell migration in hindbrain
|
GO:0021535 |
16 |
0.071
|
|
|
|
male sex determination
|
GO:0030238 |
14 |
0.071
|
|
|
|
prostate gland growth
|
GO:0060736 |
13 |
0.070
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.070
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.069
|
|
|
|
dorsal ventral neural tube patterning
|
GO:0021904 |
28 |
0.069
|
|
|
|
regulation of lens epithelial cell proliferation
|
GO:2001109 |
1 |
0.069
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.068
|
|
|
|
chromatin silencing at rdna
|
GO:0000183 |
3 |
0.068
|
|
|
|
positive regulation of skeletal muscle tissue regeneration
|
GO:0043415 |
4 |
0.068
|
|
|
|
otic vesicle development
|
GO:0071599 |
14 |
0.068
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.068
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.068
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.067
|
|
|
|
heart induction
|
GO:0003129 |
2 |
0.067
|
|
|
|
trigeminal nerve development
|
GO:0021559 |
10 |
0.067
|
|
|
|
positive regulation of protein localization to nucleus
|
GO:1900182 |
30 |
0.067
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.066
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.066
|
|
|
|
endoderm formation
|
GO:0001706 |
20 |
0.066
|
Human |
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.065
|
|
|
|
lens morphogenesis in camera type eye
|
GO:0002089 |
24 |
0.065
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.065
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.065
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.065
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.064
|
|
|
|
mineralocorticoid biosynthetic process
|
GO:0006705 |
1 |
0.063
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.063
|
|
|
|
ectodermal placode morphogenesis
|
GO:0071697 |
16 |
0.062
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.062
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003256 |
6 |
0.062
|
|
|
|
germ line sex determination
|
GO:0018992 |
3 |
0.062
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.062
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.062
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.062
|
|
|
|
regulation of gene silencing by mirna
|
GO:0060964 |
4 |
0.062
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.061
|
|
|
|
corticotropin hormone secreting cell differentiation
|
GO:0060128 |
3 |
0.061
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.061
|
|
|
|
definitive hemopoiesis
|
GO:0060216 |
20 |
0.061
|
|
|
|
metanephric nephron tubule development
|
GO:0072234 |
16 |
0.061
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.061
|
|
|
|
metanephric tubule development
|
GO:0072170 |
18 |
0.060
|
|
|
|
negative regulation of mesodermal cell fate specification
|
GO:0042662 |
3 |
0.060
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.060
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.060
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.060
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.060
|
|
|
|
olfactory placode formation
|
GO:0030910 |
4 |
0.059
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.059
|
|
|
|
negative regulation of myoblast differentiation
|
GO:0045662 |
18 |
0.059
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.059
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.059
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.059
|
|
|
|
pulmonary valve formation
|
GO:0003193 |
1 |
0.058
|
|
|
|
positive regulation of lens epithelial cell proliferation
|
GO:2001111 |
1 |
0.058
|
|
|
|
planar cell polarity pathway involved in neural tube closure
|
GO:0090179 |
14 |
0.058
|
|
|
|
transcription from rna polymerase i promoter
|
GO:0006360 |
13 |
0.058
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.058
|
|
|
|
sinoatrial node cell differentiation
|
GO:0060921 |
3 |
0.057
|
|
|
|
male germ line sex determination
|
GO:0019100 |
2 |
0.057
|
|
|
|
positive regulation of skeletal muscle fiber differentiation
|
GO:1902811 |
2 |
0.057
|
|
|
|
retinal ganglion cell axon guidance
|
GO:0031290 |
18 |
0.057
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.057
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.057
|
|
|
|
inositol trisphosphate biosynthetic process
|
GO:0032959 |
5 |
0.056
|
|
|
|
ureter urothelium development
|
GO:0072190 |
3 |
0.056
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.056
|
|
|
|
regulation of heart looping
|
GO:1901207 |
1 |
0.056
|
|
|
|
negative regulation of canonical wnt signaling pathway involved in neural plate anterior posterior pattern formation
|
GO:0060829 |
1 |
0.056
|
|
|
|
neuron fate specification
|
GO:0048665 |
30 |
0.056
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.055
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.055
|
|
|
|
regulation of gene silencing by rna
|
GO:0060966 |
5 |
0.055
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.055
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.054
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.054
|
|
|
|
regulation of extracellular matrix assembly
|
GO:1901201 |
2 |
0.054
|
|
|
|
juxtaglomerular apparatus development
|
GO:0072051 |
1 |
0.054
|
|
|
|
regulation of exocytosis
|
GO:0017157 |
61 |
0.054
|
|
|
|
forebrain neuron fate commitment
|
GO:0021877 |
13 |
0.053
|
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
3 |
0.053
|
|
|
|
negative regulation of glial cell proliferation
|
GO:0060253 |
4 |
0.053
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.052
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.052
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.052
|
|
|
|
positive regulation of skeletal muscle cell differentiation
|
GO:2001016 |
4 |
0.052
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.052
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.052
|
|
|
|
positive regulation of alcohol biosynthetic process
|
GO:1902932 |
5 |
0.052
|
|
|
|
stem cell division
|
GO:0017145 |
30 |
0.051
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.051
|
|
|
|
rna 3 end processing
|
GO:0031123 |
20 |
0.051
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.051
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.051
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.051
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.051
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.051
|
|
|
|
positive regulation of tongue muscle cell differentiation
|
GO:2001037 |
2 |
0.050
|
|
|
|
regulation of inositol trisphosphate biosynthetic process
|
GO:0032960 |
3 |
0.050
|
|
|
|
histone h4 deacetylation
|
GO:0070933 |
4 |
0.050
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.050
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.049
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.049
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.049
|
|
|
|
preganglionic parasympathetic nervous system development
|
GO:0021783 |
17 |
0.049
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.049
|
|
|
|
regulation of mesenchymal cell apoptotic process
|
GO:2001053 |
14 |
0.049
|
|
|
|
cardiac atrium development
|
GO:0003230 |
24 |
0.049
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.049
|
|
|
|
immunoglobulin production involved in immunoglobulin mediated immune response
|
GO:0002381 |
43 |
0.048
|
|
|
|
transforming growth factor beta secretion
|
GO:0038044 |
1 |
0.048
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.048
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.048
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.047
|
|
|
|
mesenchymal stem cell maintenance involved in nephron morphogenesis
|
GO:0072038 |
7 |
0.047
|
|
|
|
metanephric epithelium development
|
GO:0072207 |
21 |
0.047
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.047
|
|
|
|
intrahepatic bile duct development
|
GO:0035622 |
2 |
0.046
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.046
|
|
|
|
regulation of immunoglobulin production
|
GO:0002637 |
42 |
0.046
|
|
|
|
primary prostatic bud elongation
|
GO:0060516 |
2 |
0.046
|
|
|
|
positive regulation of mesonephros development
|
GO:0061213 |
20 |
0.045
|
|
|
|
neural crest cell migration
|
GO:0001755 |
32 |
0.045
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.045
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.045
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.045
|
|
|
|
metanephric nephron morphogenesis
|
GO:0072273 |
19 |
0.045
|
|
|
|
positive regulation of secondary heart field cardioblast proliferation
|
GO:0072513 |
4 |
0.044
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.044
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.044
|
|
|
|
mammary gland formation
|
GO:0060592 |
9 |
0.044
|
|
|
|
cellular response to estrogen stimulus
|
GO:0071391 |
12 |
0.044
|
|
|
|
negative regulation of chromatin silencing
|
GO:0031936 |
1 |
0.043
|
|
|
|
regulation of organ formation
|
GO:0003156 |
34 |
0.043
|
|
|
|
axis elongation
|
GO:0003401 |
30 |
0.043
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.043
|
|